Phoenix Biotech Acquisition Corp. reported earnings results for the seven months ended December 31, 2021. For the seven months, the company reported net loss was USD 0.315547 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3044 USD | +6.28% |
|
+4.97% | -97.23% |
06-24 | CERo Therapeutics Holdings, Inc.(NasdaqGM:CERO) added to S&P TMI Index | CI |
06-06 | CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236 | CI |
1st Jan change | Capi. | |
---|---|---|
-97.23% | 4.58M | |
+16.13% | 122B | |
+19.65% | 113B | |
+18.75% | 26.49B | |
-23.84% | 19.4B | |
-18.49% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Seven Months Ended December 31, 2021